TIDMFUM
RNS Number : 4757P
Futura Medical PLC
10 October 2023
Futura Medical plc
("Futura" or the "Company")
Directors'/PDMR Dealing and Grant of Options
10 October 2023
Futura Medical plc (AIM: FUM) (the "Company"), the
pharmaceutical company developing innovative sexual health
products, announces a grant of 10,590,675 options over Ordinary
Shares ("Options") to employees and Directors.
Grant of Options
The Company has granted a total of 10,590,675 Options of which
4,084,681 have been awarded to Directors as detailed below.
All Options have been granted under existing schemes, granting
was subject to the achievement of performance-based milestones and
will vest equally over 3 years to October 2026 with 25% of the
Options granted with immediate vesting. The main ongoing vesting
condition is that the individual remains an employee or Director at
the time of vesting.
Director Number of Options granted Exercise price Total number of Options held following grant
James Barder 1,450,211 0.2p 3,615,927
Angela Hildreth 1,267,742 0.2p 3,040,082
Ken James 1,366,728 0.2p 3,375,953
Full details of the Non-Executive Directors' remuneration will
be included in the Company's Annual Report & Accounts.
S
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
Email: Investor.relations@futuramedical.com
Tel: +44 (0) 1483 685 670
www.Futuramedical.com
Nomad and Sole Advisor
Liberum
Phil Walker/ Richard Lindley/ Ben Cryer
Tel: +44 (0) 20 3100 2000
For media enquiries please contact:
Optimum Strategic Communications
Nick Bastin/ Jonathan Edwards/ Zoe Bolt/ Elena Bates
Email: futuramedical@optimumcomms.com
Tel: +44 (0) 203 882 9621
About Futura Medical plc
Futura Medical plc (AIM: FUM), is a pharmaceutical company
developing a portfolio of innovative products based on its
proprietary, transdermal DermaSys(R) technology. Each DermaSys(R)
formulation is separately patented and specifically tailored for
the selected indication and application, as well as being optimised
for clinical efficacy, safety, administration and patient
convenience. The products are developed for the prescription and
consumer healthcare markets as appropriate. Development and
commercialisation strategies are designed to maximise product
differentiation and value creation whilst minimising risk.
MED3000 is Futura's topical gel formulation that is a novel
treatment for erectile dysfunction (ED) through a unique
evaporative mode of action. Futura has conducted two Phase 3
studies using MED3000 in ED; FM57 study which enabled Futura to be
granted a CE Mark in 2021 and FM71 which enabled Futura to be
granted US marketing authorisation. Both studies demonstrated that
MED3000 presents an effective clinically proven treatment for ED
with a rapid speed of onset and a favourable benefit versus risk
profile ideally suited for an 'Over the Counter'
classification.
Eroxon(R) is FDA approved in the US, CE marked in Europe and
UKCA marked in the UK as a clinically proven topical treatment for
adult men with erectile dysfunction under the brand Eroxon(R) with
a key claim of "Helps you get an erection within 10 minutes".
Eroxon(R) is the agreed brand name in certain regions such as the
EU whereas MED3000 continues to be the internal code name used by
the Company and also in reference to countries where regulatory
approval or commercial distribution agreements have not yet been
achieved. www.eroxon.com
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange. www.futuramedical.com
.
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name James Barder
-------------------------- ---------------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
-------------------------- ---------------------------------------
b) LEI 21380053QLT46UNV2303
-------------------------- ---------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Options over Ordinary shares of 0.2p
type of instrument each
Identification code GB0033278473
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of Options over Ordinary Shares
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
nil 1,450,211
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
-------------------------- ---------------------------------------
e) Date of the transaction 9 October 2023
-------------------------- ---------------------------------------
f) Place of the transaction Outside of trading venue
-------------------------- ---------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Angela Hildreth
-------------------------- ---------------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
-------------------------- ---------------------------------------
b) LEI 21380053QLT46UNV2303
-------------------------- ---------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Options over Ordinary shares of 0.2p
type of instrument each
Identification code GB0033278473
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of Options over Ordinary Shares
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
nil 1,267,742
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
-------------------------- ---------------------------------------
e) Date of the transaction 9 October 2023
-------------------------- ---------------------------------------
f) Place of the transaction Outside of trading venue
-------------------------- ---------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Ken James
-------------------------- ---------------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
-------------------------- ---------------------------------------
b) LEI 21380053QLT46UNV2303
-------------------------- ---------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Options over Ordinary shares of 0.2p
type of instrument each
Identification code GB0033278473
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of Options over Ordinary Shares
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
nil 1,366,728
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
-------------------------- ---------------------------------------
e) Date of the transaction 9 October 2023
-------------------------- ---------------------------------------
f) Place of the transaction Outside of trading venue
-------------------------- ---------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFSFFMUEDSEIS
(END) Dow Jones Newswires
October 10, 2023 02:00 ET (06:00 GMT)
Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De May 2023 a May 2024
